Novavax Inc said it will manufacture its COVID\u002D19 vaccine in Canada after its use in children aged between 12 and 17 years was allowed.
Production of test batches of the protein-based vaccine, Nuvaxovid, will begin at the Montreal manufacturing centre by early 2023, the company said.Sign up to receive daily headline news from the Ottawa SUN, a division of Postmedia Network Inc.By clicking on the sign up button you consent to receive the above newsletter from Postmedia Network Inc. You may unsubscribe any time by clicking on the unsubscribe link at the bottom of our emails. Postmedia Network Inc.
Earlier this year, the Canadian health regulator had allowed the use of Novavax’s vaccine for primary series and as a booster in adults above 18 years of age. Hurt by a global supply glut in COVID-19 vaccine and waning demand, Novavax cut its full-year revenue forecast last month to a range of $2 billion and $2.3 billion. Shots from rivals Pfizer/BioNtech and Moderna were approved last year for initial vaccination of adolescents in Canada, hurting the vaccine maker further.Share this article in your social network
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Novavax to make COVID-19 vaccine shots in CanadaNovavax Inc said it will manufacture its COVID\u002D19 vaccine in Canada after its use in children aged between 12 and 17 years was allowed.
Read more »
Novavax to make COVID-19 vaccine shots in CanadaNovavax Inc said it will manufacture its COVID\u002D19 vaccine in Canada after its use in children aged between 12 and 17 years was allowed.
Read more »
COVID-19 and flu: 5 COVID-19 deaths, flu positivity up slightlyOttawa Public Health is reporting five more deaths from COVID-19 in its Tuesday update and a slight increase in the positivity rate for influenza.
Read more »
COVID-19 vaccines worth $1B to be wasted by CanadaAuditor General Karen Hogan said there were steps the government could and should have taken to avoid some of this wastage
Read more »
Expired COVID-19 vaccines to cost Canada $1 billion: AG report\u0027We found that the Public Health Agency of Canada was unsuccessful in its efforts to minimize vaccine wastage\u0027
Read more »
COVID-19 benefits helped economy rebound, but post-payment verification lacking: AGCanada\u0027s auditor general says COVID\u002D19 benefits were delivered quickly and helped mitigate economic suffering
Read more »